ENTX Entera Bio Ltd. - Ordinary Shares
$3,03
Prix · Aoû 19, 2026
Données fondamentales au Aoû 7, 2026
Fourchette 52 semaines
$1–$4
64% of range
Note des analystes
BUY
7 analysts
Objectif de cours
$9
+197% upside
P/E (TTM)
12.1
ROE
-75.4%
Marge nette
-27235.7%
ENTX Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$3.03
Capitalisation Boursière
$140M
P/E (TTM)
12.1
BPA (TTM)
$0.25
Revenus (TTM)
$42.0K
Rendement div.
—
ROE
-75.4%
Dette/Capitaux propres
—
Fourchette 52 semaines
$1 – $4
ENTX Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
$42.0K
2020-12-31
→
2025-12-31
BPA
$0.25
2021-12-31
→
2025-12-31
Flux de trésorerie libre
$-7M
2022-12-31
→
2025-12-31
Marges
-27235.7%
2022-12-31
→
2025-12-31
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
ENTX
Médiane des pairs
P/E (TTM)
12.1
13.4
P/S (TTM)
3332.2
10.7
P/B
10.7
4.2
Price / FCF (Cours / FCF)
-18.7
—
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
ENTX
Médiane des pairs
Gross Margin (Marge Brute)
0.00%
62.1%
Operating Margin (Marge d'exploitation)
-27450.0%
—
Net Profit Margin (Marge nette)
-27235.7%
-257.8%
ROA
-90.1%
-28.7%
ROE
-75.4%
-40.1%
ROIC
-88.0%
—
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
ENTX
Médiane des pairs
Current Ratio (Ratio de liquidité)
6.9
5.5
Quick Ratio (Ratio de liquidité réduite)
3.2
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
ENTX
Médiane des pairs
Revenue YoY (Chiffre d'affaires YoY)
-76.8%
—
Revenue CAGR 3Y (CAGR du chiffre d'affaires 3 ans)
-32.1%
—
Revenue CAGR 5Y (CAGR du chiffre d'affaires 5 ans)
-35.1%
—
EPS YoY (BPA Année/Année)
0.00%
—
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
ENTX
Médiane des pairs
ENTX Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
ACHAT
7 analystes
- Achat fort 2 28,6%
- Achat 4 57,1%
- Conserver 1 14,3%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
1 analystes · 2026-08-14
Bas
$9.00
Haut
$9.00
Objectif médian
$9.00
+197,0%
Objectif moyen
$9.00
+197,0%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
0.02%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 30 juin 2026 | $-0.14 | $-0.08 | -0.06% |
| 31 mars 2026 | $-0.07 | $-0.15 | 0.08% |
| 31 décembre 2025 | $-0.07 | $-0.09 | 0.02% |
| 30 septembre 2025 | $-0.07 | $-0.09 | 0.02% |
| 30 juin 2025 | $-0.06 | $-0.11 | 0.05% |
| 31 mars 2025 | $-0.06 | $-0.07 | 0.01% |
| 31 décembre 2024 | $-0.06 | $-0.08 | 0.02% |
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| ENTX | $90M | 7.8 | -76.8% | -27235.7% | -75.4% | 0.00% |
| URGN | $1.13B | — | 21.4% | -139.8% | 154.4% | 88.7% |
| KMDA | — | — | — | — | — | — |
| CGEN | — | — | — | — | — | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 16
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $42.0K | $181.0K | $0 | $134.0K | $571.0K | $365.0K | |
| Cost of Revenue | $42.0K | $172.0K | $0 | $101.0K | $373.0K | $300.0K | |
| Gross Profit | $0 | $9.0K | $0 | $33.0K | $198.0K | $65.0K | |
| R&D Expense | $6M | $4M | $5M | $6M | $7M | $6M | |
| SG&A Expense | $398.0K | $340.0K | $4M | $7M | $6M | $5M | |
| Operating Expenses | $12M | $10M | $9M | $13M | $12M | $11M | |
| Operating Income | $-12M | $-10M | $-9M | $-13M | $-12M | $-11M | |
| Other Non-op | $90.0K | $58.0K | $31.0K | $83.0K | $-29.0K | $-28.0K | |
| Pretax Income | $-11M | $-10M | $-9M | $-13M | $-12M | $-11M | |
| Income Tax | $0 | $14.0K | $29.0K | $137.0K | $-59.0K | $20.0K | |
| Net Income | $-11M | $-10M | $-9M | $-13M | $-12M | $-11M | |
| EPS (Basic) | $0.25 | $0.25 | $0.31 | $0.45 | $0.47 | · | |
| EPS (Diluted) | $0.25 | $0.25 | $0.31 | $0.45 | $0.47 | · | |
| Shares (Basic) | 46,191,067 | 37,650,179 | 29,007,794 | 28,808,090 | 26,133,770 | · | |
| Shares (Diluted) | 46,191,067 | 37,650,179 | 29,007,794 | 28,808,090 | 26,133,770 | · | |
| EBITDA | $-12M | $-10M | $-9M | $-13M | · | · |
Bilan 18
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $7M | $9M | $11M | $12M | $25M | $9M | |
| Receivables | $0 | $126.0K | $0 | $246.0K | $183.0K | $255.0K | |
| Prepaid Expense | $415.0K | $29.0K | $238.0K | $294.0K | · | · | |
| Other Current Assets | $107.0K | $186.0K | $238.0K | $294.0K | $254.0K | $261.0K | |
| Current Assets | $15M | $9M | $11M | $13M | $25M | $9M | |
| PP&E (Net) | $134.0K | $57.0K | $100.0K | $139.0K | $156.0K | $192.0K | |
| Total Assets | $16M | $9M | $12M | $13M | $26M | $10M | |
| Accounts Payable | $448.0K | $132.0K | $83.0K | $17.0K | $166.0K | $164.0K | |
| Current Liabilities | $2M | $1M | $1M | $1M | $3M | $2M | |
| Capital Leases | $260.0K | $102.0K | $256.0K | $0 | $123.0K | $243.0K | |
| Other Non-current Liabilities | $393.0K | $0 | · | · | · | · | |
| Total Liabilities | $3M | $1M | $1M | $1M | $3M | $2M | |
| Common Stock | $1.0K | $1.0K | $1.0K | · | · | · | |
| Retained Earnings | $-125M | $-114M | $-104M | $-95M | $-82M | $-70M | |
| AOCI | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | |
| Stockholders' Equity | $13M | $8M | $10M | $12M | $23M | $8M | |
| Liabilities + Equity | $16M | $9M | $12M | $13M | $26M | $10M | |
| Shares Outstanding | 46,178,630 | 38,837,220 | 35,476,341 | 28,809,922 | 28,804,411 | 21,057,922 |
Flux de trésorerie 11
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $3M | $3M | $2M | $2M | $2M | $901.0K | |
| Deferred Tax | $0 | $14.0K | $29.0K | $174.0K | $-217.0K | $0 | |
| Operating Cash Flow | $-7M | $-7M | $-7M | $-12M | $-9M | $-11M | |
| CapEx | $107.0K | $3.0K | $17.0K | $47.0K | $17.0K | $53.0K | |
| Investing Cash Flow | $-107.0K | $-3.0K | $-17.0K | $-102.0K | $-17.0K | $-53.0K | |
| Stock Issued | $6M | $4M | $5.0K | $0 | $22M | $3M | |
| Net Stock Activity | $6M | $4M | $5.0K | $0 | · | · | |
| Financing Cash Flow | $14M | $4M | $6M | $13.0K | $25M | $4M | |
| Net Change in Cash | $6M | $-2M | $-1M | $-13M | $16M | $-7M | |
| Taxes Paid | · | · | $0 | $165.0K | $2.0K | $89.0K | |
| Free Cash Flow | $-7M | $-7M | $-7M | $-13M | · | · |
Rentabilité 8
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 0.00% | 5.0% | · | 24.6% | · | · | |
| Operating Margin | -27450.0% | -5295.6% | · | -9714.2% | · | · | |
| Net Margin | -27235.7% | -5271.3% | · | -9754.5% | · | · | |
| Pretax Margin | -27235.7% | -5263.5% | · | -9652.2% | · | · | |
| EBITDA Margin | -27450.0% | -5295.6% | · | -9714.2% | · | · | |
| ROA | -90.1% | -90.2% | -71.4% | -66.8% | · | · | |
| ROE | -75.4% | -131.3% | -106.9% | -100.3% | · | · | |
| ROIC | -88.0% | -118.8% | -85.9% | -111.9% | · | · |
Liquidité et Solvabilité 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 6.9 | 7.6 | 10.3 | 9.6 | · | · | |
| Quick Ratio | 3.2 | 7.5 | 10.1 | 9.4 | · | · |
Efficacité 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | · | · | |
| Receivables Turnover | 0.7 | 2.9 | 0.0 | 0.6 | · | · |
Taux de croissance 5
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | -76.8% | · | · | -76.5% | 56.4% | · | |
| Revenue CAGR 3Y | -32.1% | -31.8% | · | · | · | · | |
| Revenue CAGR 5Y | -35.1% | · | · | · | · | · | |
| EPS YoY | 0.00% | -19.4% | -31.1% | -4.3% | · | · | |
| EPS CAGR 3Y | -17.8% | -19.0% | · | · | · | · |
Valorisation (TTM) 10
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $42.0K | $181.0K | $0 | $134.0K | $571.0K | · | |
| Net Income TTM | $-11M | $-10M | $-9M | $-13M | $-12M | · | |
| Market Cap | $90M | $82M | $21M | $21M | · | · | |
| P/E | 7.8 | 8.5 | 1.9 | 1.6 | 6.0 | · | |
| P/S | 2133.0 | 454.9 | · | 156.9 | · | · | |
| P/B | 6.8 | 10.2 | 2.0 | 1.8 | · | · | |
| P / Tangible Book | 6.8 | 10.2 | 2.0 | 1.8 | 3.6 | · | |
| P / Cash Flow | -12.2 | -12.1 | -2.9 | -1.7 | · | · | |
| P / FCF | -12.0 | -12.1 | -2.9 | -1.7 | · | · | |
| Earnings Yield | 12.9% | 11.8% | 51.7% | 61.6% | 16.7% | · |
Compte de résultat 16
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $42.0K | $82.0K | $42.0K | $57.0K | $0 | $0 | $0 | $0 | $0 | $14.0K | $8.0K | |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 | $42.0K | $82.0K | $42.0K | $48.0K | $0 | $0 | $0 | $0 | $0 | $8.0K | $6.0K | |
| Gross Profit | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $9.0K | · | $0 | $0 | $0 | $0 | $6.0K | $2.0K | |
| R&D Expense | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $735.0K | $1M | $1M | $1M | $931.0K | $1M | $1M | |
| SG&A Expense | $124.0K | $128.0K | $-1M | $122.0K | $103.0K | $123.0K | $-1M | $62.0K | $134.0K | $1M | $973.0K | $1M | $1M | $1M | $2M | $1M | |
| Operating Expenses | $5M | $4M | $3M | $3M | $3M | $3M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | |
| Operating Income | $-5M | $-4M | $-3M | $-3M | $-3M | $-3M | $-2M | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M | |
| Other Non-op | $-3M | $34.0K | $26.0K | $56.0K | $12.0K | $-4.0K | $-7.0K | $0 | $20.0K | $45.0K | $-32.0K | $36.0K | $5.0K | $22.0K | $-13.0K | $-8.0K | |
| Pretax Income | · | · | · | · | · | · | $-2M | $-3M | · | · | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M | |
| Income Tax | · | · | · | · | · | · | $14.0K | $0 | · | · | $0 | $29.0K | $0 | $0 | $-46.0K | $194.0K | |
| Net Income | $-7M | $-4M | $-3M | $-3M | $-3M | $-3M | $-2M | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M | |
| EPS (Basic) | $0.14 | $0.07 | $0.06 | $0.07 | $0.06 | $0.06 | $0.06 | $0.08 | $0.06 | $0.05 | $0.07 | $0.08 | $0.08 | $0.08 | $0.10 | $0.11 | |
| EPS (Diluted) | $0.14 | $0.07 | $0.06 | $0.07 | $0.06 | $0.06 | $0.06 | $0.08 | $0.06 | $0.05 | $0.07 | $0.08 | $0.08 | $0.08 | $0.10 | $0.11 | |
| Shares (Basic) | 50,451,232 | 47,756,409 | -91,112,838 | 47,089,814 | 46,836,700 | 43,377,391 | -73,820,022 | 37,644,612 | 37,090,160 | 36,735,429 | -57,428,455 | 28,813,952 | 28,812,375 | 28,809,922 | -57,614,266 | 28,809,922 | |
| Shares (Diluted) | 50,451,232 | 47,756,409 | -91,112,838 | 47,089,814 | 46,836,700 | 43,377,391 | -73,820,022 | 37,644,612 | 37,090,160 | 36,735,429 | -57,428,455 | 28,813,952 | 28,812,375 | 28,809,922 | -57,614,266 | 28,809,922 | |
| EBITDA | $-5M | $-4M | · | $-3M | $-3M | $-3M | · | $-3M | $-2M | $-2M | · | $-2M | $-2M | $-2M | · | $-3M |
Bilan 18
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $11M | $4M | $7M | $9M | $11M | $13M | $9M | $7M | $9M | $9M | $11M | $8M | $9M | $11M | $12M | $14M | |
| Receivables | · | · | $0 | $0 | $0 | $126.0K | $126.0K | $42.0K | $57.0K | · | $0 | $0 | $29.0K | $29.0K | $246.0K | $233.0K | |
| Prepaid Expense | $465.0K | $566.0K | $37.0K | $405.0K | $438.0K | $519.0K | $29.0K | $383.0K | $482.0K | $562.0K | · | $431.0K | $650.0K | · | · | · | |
| Other Current Assets | $144.0K | $256.0K | $415.0K | $262.0K | $192.0K | $165.0K | $186.0K | $89.0K | $67.0K | $39.0K | $238.0K | $263.0K | $354.0K | $653.0K | $294.0K | $634.0K | |
| Current Assets | $19M | $12M | $15M | $17M | $19M | $21M | $9M | $7M | $10M | $10M | $11M | $8M | $10M | $11M | $13M | $15M | |
| PP&E (Net) | $121.0K | $127.0K | $134.0K | $114.0K | $79.0K | $57.0K | $57.0K | $65.0K | $76.0K | $87.0K | $100.0K | $108.0K | $122.0K | $136.0K | $139.0K | $152.0K | |
| Total Assets | $19M | $13M | $16M | $17M | $20M | $22M | $9M | $8M | $10M | $10M | $12M | $9M | $10M | $12M | $13M | $16M | |
| Accounts Payable | $575.0K | $274.0K | $448.0K | $216.0K | $383.0K | $134.0K | $132.0K | $184.0K | $69.0K | $66.0K | $83.0K | $564.0K | $240.0K | $150.0K | $17.0K | $413.0K | |
| Current Liabilities | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $1M | $1M | $1M | |
| Capital Leases | $226.0K | $263.0K | $260.0K | $41.0K | $9.0K | $51.0K | $102.0K | $147.0K | $179.0K | $224.0K | $256.0K | $271.0K | $316.0K | · | $0 | $3.0K | |
| Other Non-current Liabilities | · | · | $393.0K | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $12M | $2M | $3M | $2M | $2M | $2M | $1M | $1M | $2M | $1M | $1M | $2M | $2M | $2M | $1M | $1M | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | · | · | · | · | · | |
| Retained Earnings | $-136M | $-129M | $-125M | $-122M | $-119M | $-116M | $-114M | $-112M | $-109M | $-106M | $-104M | $-102M | $-100M | $-98M | $-95M | $-92M | |
| AOCI | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | |
| Stockholders' Equity | $7M | $11M | $13M | $15M | $17M | $19M | $8M | $6M | $9M | $9M | $10M | $6M | $8M | $10M | $12M | $14M | |
| Liabilities + Equity | $19M | $13M | $16M | $17M | $20M | $22M | $9M | $8M | $10M | $10M | $12M | $9M | $10M | $12M | $13M | $16M | |
| Shares Outstanding | 49,290,233 | 46,622,239 | 46,178,630 | 45,664,506 | 45,452,167 | 45,420,677 | 38,837,220 | 36,512,214 | 36,314,579 | 35,526,281 | 35,476,341 | 28,813,952 | 28,813,952 | 28,809,922 | 28,809,922 | 28,809,922 |
Flux de trésorerie 11
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $624.0K | $672.0K | $710.0K | $927.0K | $509.0K | $604.0K | $566.0K | $928.0K | $598.0K | $464.0K | $318.0K | $383.0K | $472.0K | $516.0K | $477.0K | $110.0K | |
| Deferred Tax | · | · | · | · | · | · | $14.0K | · | · | · | $0 | $29.0K | $0 | $0 | $23.0K | $214.0K | |
| Operating Cash Flow | $-3M | $-3M | $-2M | $-3M | $-2M | $-1M | $-1M | $-2M | $-1M | $-2M | $-3M | $-2M | $-2M | $-2M | $-2M | $-3M | |
| CapEx | $3.0K | $0 | $27.0K | $43.0K | $29.0K | $8.0K | $3.0K | $0 | $0 | $0 | $5.0K | $0 | $1.0K | $11.0K | $3.0K | $2.0K | |
| Investing Cash Flow | $-3.0K | $0 | $-27.0K | $-43.0K | $-29.0K | $-8.0K | $-3.0K | $0 | $0 | $0 | $-5.0K | $0 | $-1.0K | $-11.0K | $-3.0K | $-57.0K | |
| Stock Issued | $0 | $0 | $0 | $71.0K | $0 | $6M | $3M | $19.0K | $620.0K | $0 | $0 | $0 | · | · | $0 | $0 | |
| Net Stock Activity | · | $0 | · | · | · | $6M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $10M | $130.0K | $174.0K | $250.0K | $-51.0K | $13M | $3M | $13.0K | $1M | $30.0K | $6M | $0 | $5.0K | $0 | $0 | $0 | |
| Net Change in Cash | · | · | · | · | $-2M | $12M | $2M | $-2M | $-119.0K | $-2M | $3M | $-2M | $-2M | $-2M | $-2M | $-3M | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | |
| Free Cash Flow | · | $-3M | · | · | · | $-1M | · | · | · | $-2M | · | · | · | $-2M | · | · |
Rentabilité 8
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | 0.00% | · | 0.00% | 15.8% | · | · | · | · | · | · | 25.0% | |
| Operating Margin | · | · | · | · | · | -6102.4% | · | -7192.9% | -3798.2% | · | · | · | · | · | · | -35812.5% | |
| Net Margin | · | · | · | · | · | -6111.9% | · | -7192.9% | -3763.2% | · | · | · | · | · | · | -38337.5% | |
| Pretax Margin | · | · | · | · | · | · | · | -7192.9% | · | · | · | · | · | · | · | -35912.5% | |
| EBITDA Margin | · | · | · | · | · | -6102.4% | · | -7192.9% | -3798.2% | · | · | · | · | · | · | -35812.5% | |
| ROA | -37.4% | -20.2% | · | -25.4% | -17.9% | -16.1% | · | -37.0% | -20.9% | -18.5% | · | -19.7% | -15.8% | -12.9% | · | -39.5% | |
| ROE | -59.6% | -23.3% | · | -29.5% | -20.6% | -18.2% | · | -47.6% | -25.6% | -21.3% | · | -23.2% | -18.2% | -14.7% | · | -42.9% | |
| ROIC | · | · | · | · | · | · | · | -46.8% | · | · | · | -38.7% | -28.3% | -21.9% | · | -21.4% |
Liquidité et Solvabilité 2
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.0 | 7.9 | · | 10.8 | 10.5 | 13.1 | · | 6.6 | 7.4 | 8.7 | · | 4.0 | 5.3 | 7.6 | · | 12.7 | |
| Quick Ratio | 5.4 | 2.6 | · | 5.5 | 5.9 | 7.8 | · | 6.3 | 7.0 | 8.2 | · | 3.7 | 4.9 | 7.2 | · | 12.2 |
Efficacité 2
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | · | · | · | 0.0 | 0.0 | 0.5 | · | 2.0 | 1.3 | · | · | 0.0 | 0.0 | 0.0 | · | 0.1 |
Valorisation (TTM) 10
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $42.0K | · | $84.0K | $141.0K | $141.0K | · | $99.0K | $57.0K | $0 | · | $8.0K | $52.0K | $120.0K | · | $260.0K | |
| Net Income TTM | $-17M | $-12M | · | $-11M | $-10M | $-10M | · | $-10M | $-9M | $-9M | · | $-10M | $-11M | $-12M | · | $-13M | |
| Market Cap | $87M | $52M | · | $88M | $86M | $77M | · | $69M | $67M | $59M | · | $21M | $24M | $33M | · | $30M | |
| P/E | 5.2 | 4.3 | · | 7.1 | 7.3 | 6.8 | · | 7.0 | 6.8 | 5.8 | · | 2.1 | 2.2 | 2.7 | · | 2.3 | |
| P/S | · | 1232.2 | · | 1043.8 | 612.5 | 547.6 | · | 700.7 | 1172.3 | · | · | 2611.3 | 467.1 | 278.5 | · | 115.2 | |
| P/B | 12.0 | 4.8 | · | 5.8 | 5.0 | 4.0 | · | 10.8 | 7.8 | 6.7 | · | 3.3 | 3.0 | 3.3 | · | 2.1 | |
| P / Tangible Book | 12.0 | 4.8 | · | 5.8 | 5.0 | 4.0 | · | 10.8 | 7.8 | 6.7 | · | 3.3 | 3.0 | 3.3 | · | 2.1 | |
| P / Cash Flow | · | -16.7 | · | · | · | -55.0 | · | · | · | -31.9 | · | · | · | -20.8 | · | · | |
| P / FCF | · | -16.7 | · | · | · | -54.7 | · | · | · | -31.9 | · | · | · | -20.6 | · | · | |
| Earnings Yield | 19.2% | 23.4% | · | 14.1% | 13.7% | 14.7% | · | 14.2% | 14.7% | 17.4% | · | 48.3% | 45.1% | 37.1% | · | 44.2% |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenu | $42.0K | $181.0K | $0 | $134.0K | $571.0K |
| Marge Brute % | 0.00% | 5.0% | — | 24.6% | — |
| Marge d'exploitation % | -27450.0% | -5295.6% | — | -9714.2% | — |
| Résultat net | $-11M | $-10M | $-9M | $-13M | $-12M |
| BPA dilué | $0.25 | $0.25 | $0.31 | $0.45 | $0.47 |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio de liquidité | 6.9 | 7.6 | 10.3 | 9.6 | — |
| Ratio de liquidité réduite | 3.2 | 7.5 | 10.1 | 9.4 | — |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $-7M | $-7M | $-7M | $-13M | — |
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Détenteurs institutionnels (13F) 29 déclarants · $18.8M total · Au 30 juin 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
Activité institutionnelle — Q2 2026 vs trimestre précédent
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 8 (0 vs T. préc.) | 6 (+2 vs T. préc.) | 8 (+3 vs T. préc.) | 6 (-1 vs T. préc.) | +3.0M |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| Knoll Capital Management, LLC | $10 410 925 | 5 881 879 | 55,50% | Actions |
| BVF INC/IL | $4 292 250 | 2 425 000 | 22,88% | Actions |
| Siren, L.L.C. | $1 303 529 | 736 457 | 6,95% | Actions |
| RENAISSANCE TECHNOLOGIES LLC | $652 859 | 368 847 | 3,48% | Actions |
| Parkman Healthcare Partners LLC | $485 860 | 274 497 | 2,59% | Actions |
| PNC Financial Services Group, Inc. | $483 265 | 273 031 | 2,58% | Actions |
| Seven Fleet Capital Management LP | $338 697 | 191 354 | 1,81% | Actions |
| HighTower Advisors, LLC | $132 935 | 74 573 | 0,71% | Actions |
| Schonfeld Strategic Advisors LLC | $104 201 | 58 871 | 0,56% | Actions |
| TWO SIGMA SECURITIES, LLC | $86 010 | 48 593 | 0,46% | Actions |
| SIGNATURE ESTATE & INVESTMENT ADVISORS LLC | $83 771 | 47 328 | 0,45% | Actions |
| CITADEL ADVISORS LLC | $68 683 | 38 804 | 0,37% | Actions |
| JPMORGAN CHASE & CO | $67 457 | 40 883 | 0,36% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $52 937 | 29 908 | 0,28% | Actions |
| DIADEMA PARTNERS LP | $41 170 | 23 260 | 0,22% | Actions |
| XTX Topco Ltd | $36 389 | 20 559 | 0,19% | Actions |
| Gem Investment Advisors, LLC | $33 869 | 19 135 | 0,18% | Actions |
| SIMPLEX TRADING, LLC | $27 785 | 15 698 | 0,15% | Actions |
| CITADEL ADVISORS LLC | $17 877 | 10 100 | 0,10% | Option de vente |
| JANE STREET GROUP, LLC | $11 486 | 6 489 | 0,06% | Actions |
| Persistent Asset Partners Ltd | $10 409 | 5 881 | 0,06% | Actions |
| Cubist Systematic Strategies, LLC | $8 972 | 4 673 | 0,05% | Actions |
| UBS Group AG | $5 788 | 3 270 | 0,03% | Actions |
| MORGAN STANLEY | $885 | 500 | 0,00% | Actions |
| BNP PARIBAS FINANCIAL MARKETS | $708 | 400 | 0,00% | Actions |
| HRT FINANCIAL LP | $128 | 72 486 | 0,00% | Actions |
| GROUP ONE TRADING LLC | $90 | 51 | 0,00% | Actions |
| Virtu Financial LLC | $65 | 36 921 | 0,00% | Actions |
| SG Americas Securities, LLC | $25 | 13 913 | 0,00% | Actions |
Initiés de la société 17 initiés · 4 dirigeants · 5 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| Spiros Jamas | Chief Executive Officer | 18 janvier 2022 P | 10 000 | 0 | 0 | $0 |
| Ramesh Ratan | U.S.based CFO | 19 janvier 2022 P | 10 000 | 0 | 0 | $0 |
| Phillip Schwartz | President of R&D | 20 janvier 2022 P | 607 410 | 0 | 0 | $0 |
| Arthur C Santora II | Chief Medical Officer | 24 avril 2023 A | — | 0 | 0 | $0 |
| Gerald M Ostrov | Administrateur | 1 janvier 2026 A | 75 657 | 0 | 0 | $0 |
| Gerald M Lieberman | Administrateur | 1 janvier 2026 A | 338 454 | 0 | 0 | $0 |
| Ron Mayron | Administrateur | 1 janvier 2024 A | 7 000 | 0 | 0 | $0 |
| Roger Garceau | Administrateur | 1 janvier 2024 A | — | 0 | 0 | $0 |
| Gregory Burshtein | — | 7 août 2026 A | 189 033 | 0 | 0 | $0 |
| Haya Taitel | — | 7 août 2026 A | 119 269 | 1 | 0 | $11 100 |
| Dana Yaacov-Garbeli | — | 7 août 2026 A | 171 441 | 0 | 0 | $0 |
| Yonatan Malca | — | 7 août 2026 A | 100 231 | 0 | 0 | $0 |
| Sean Ellis | — | 7 août 2026 A | 208 132 | 2 | 0 | $34 620 |
| Hillel Galitzer | — | 7 août 2026 A | 163 566 | 0 | 0 | $0 |
| Miranda Jayne Toledano | — | 7 août 2026 A | 847 135 | 1 | 0 | $19 910 |
| Geno J Germano | — | 7 août 2026 A | 65 014 | 2 | 0 | $55 800 |
| Steven D Rubin | — | 7 août 2026 A | 34 117 | 2 | 0 | $19 450 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Activistes et détenteurs de 5%+ 1 participation
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF PARTNERS L P/IL, BVF INC/IL, LAMPERT MARK N | 4 août 2026 | 9,99% | Dépôt initial | Campagne de conseil d'administration | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.